Columvi 10 mg/10 mL (1 mg/mL) injection Images
Generic Name: glofitamab
This medication has been identified as Columvi 10 mg/10 mL (1 mg/mL) injection. It is supplied by Genentech, Inc.
Columvi is used in the treatment of Diffuse Large B-Cell Lymphoma and belongs to the drug class CD20 monoclonal antibodies. Columvi 10 mg/10 mL (1 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Columvi
- Generic Name
- glofitamab
- Strength
- 10 mg/10 mL (1 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- CD20 monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0127
More about Columvi (glofitamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
